Go to Page # Page of 21

Therapeutic Strategies to Treat Patients with CNS Diseases

 Toshihide Yamashita
Description: RGMa is the potent axon growth inhibitor in the CNS. Multiple sclerosis is a demyelinating disorder of the CNS, causing patches of sclerosis in the brain and spinal cord.
Views: 2199
Domain: Medical
Category: Therapy
Development of the therapeutic strategies to
treat patients with the CNS diseases

Toshihide Yamashita
Department of Molecular Neuroscience,
Department of Neuro-Medical Science,
Graduate School of Medicine, Osaka University

Why is recovery of the injured CNS so difficult?
How does the CNS recover after injury?
No effective therapy
Spinal cord injury


Axonal injury
CNS, central nervous sy ... See more

Recent Presentations

22 July, 2019
Tine Peeters
21 July, 2019

FDA's Approach to the Opioids Crisis

FDA is working in a prioritized way in multiple areas to confront opioid overdoses while working to ensure patients receive appropriate pain treatment.

20 July, 2019